Key Metrics
4.2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
Q3
Oncology
SJR
- Q3 Oncology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.03
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Cancer
- Meningioma
- Breast cancer
- Lymphatic system
- Gynecologic cancer
- Hepatocellular carcinoma
- Soft tissue sarcoma
- Ramucirumab
- Immunotherapy
- Gallbladder
- Sentinel lymph node
- Retroperitoneal sarcoma
- Vomiting
- Gallbladder cancer
- Middle East
- Observational study
- Debulking
- Glioblastoma
- Alveolar soft part sarcoma
- Progression-free survival
Journal Specifications
| Overview | |
| Publisher | AME PUBLISHING COMPANY |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Chinese Clinical Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Triplet regimen with camrelizumab plus apatinib in combination with hepatic artery infusion chemotherapy (HAIC): a new treatment paradigm for select patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma?
- 1 Oct 24
- Chinese clinical oncology
-
Full paper
Therapeutic inhibition of isocitrate dehydrogenase mutations in glioma and cholangiocarcinoma: new insights and promises-a narrative review.
- 1 Oct 24
- Chinese clinical oncology
-
Full paper
A meta-analysis and systematic review of randomized controlled trials in combination gemcitabine with erlotinib in the pancreatic cancer.
- 1 Oct 24
- Chinese clinical oncology
-
Full paper
Short-term outcomes in obese and non-obese patients undergoing transperitoneal laparoscopic adrenalectomy for benign or malignant adrenal diseases: an updated systematic review and meta-analysis.
- 1 Oct 24
- Chinese clinical oncology
-
Full paper
Real-world evidence of survival outcomes in breast cancer subtypes after neoadjuvant chemotherapy in a Brazilian reference center.
- 1 Oct 24
- Chinese clinical oncology
-
Full paper
Phase I trials of single-agent new drugs in head and neck cancer: a scoping review.
- 1 Oct 24
- Chinese clinical oncology
Scite analysis
Powered by scite_
750 articles received 5.3k citations see all
- 88 Supporting
- 4,989 Mentioning
- 12 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 1 Errata
- 0 Expression of Concern
FAQs
How long has Chinese Clinical Oncology been actively publishing?
Chinese Clinical Oncology has been in operation since 2012 till date.
What is the publishing frequency of Chinese Clinical Oncology ?
Chinese Clinical Oncology published with a Quarterly frequency.
How many articles did Chinese Clinical Oncology publish last years ?
In 2024, Chinese Clinical Oncology published 160 articles.
What is the eISSN & pISSN for Chinese Clinical Oncology ?
For Chinese Clinical Oncology,eISSN is 2304-3873 and pISSN is2304-3865.
What is Citescore for Chinese Clinical Oncology ?
Citescore for Chinese Clinical Oncology is 4.2.
What is SNIP score for Chinese Clinical Oncology ?
SNIP score for Chinese Clinical Oncology is 1.03.
What is the SJR for Chinese Clinical Oncology ?
SJR for Chinese Clinical Oncology is Q3.
Who is the publisher of Chinese Clinical Oncology ?
AME PUBLISHING COMPANY is the publisher of Chinese Clinical Oncology.